SPECCHIA, Giorgina
 Distribuzione geografica
Continente #
NA - Nord America 25.573
EU - Europa 10.425
AS - Asia 9.375
SA - Sud America 2.575
AF - Africa 521
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 10
Totale 48.493
Nazione #
US - Stati Uniti d'America 25.178
SG - Singapore 3.825
IT - Italia 2.605
CN - Cina 2.205
DE - Germania 2.091
BR - Brasile 2.028
RU - Federazione Russa 1.873
HK - Hong Kong 1.183
SE - Svezia 1.096
GB - Regno Unito 639
VN - Vietnam 624
FR - Francia 576
FI - Finlandia 545
UA - Ucraina 439
IN - India 320
BD - Bangladesh 235
AR - Argentina 196
CA - Canada 186
CI - Costa d'Avorio 170
IQ - Iraq 122
ID - Indonesia 120
ZA - Sudafrica 113
MX - Messico 108
TR - Turchia 101
PK - Pakistan 86
PL - Polonia 86
CO - Colombia 77
BE - Belgio 73
IE - Irlanda 73
EC - Ecuador 70
JP - Giappone 67
UZ - Uzbekistan 62
SA - Arabia Saudita 61
VE - Venezuela 61
NL - Olanda 56
PH - Filippine 56
MA - Marocco 55
ES - Italia 51
CL - Cile 41
AT - Austria 37
PY - Paraguay 36
TN - Tunisia 34
MY - Malesia 33
CZ - Repubblica Ceca 31
JO - Giordania 30
KE - Kenya 28
NP - Nepal 28
LT - Lituania 27
JM - Giamaica 26
KR - Corea 26
PE - Perù 26
EG - Egitto 24
IL - Israele 21
UY - Uruguay 21
ET - Etiopia 20
KZ - Kazakistan 20
OM - Oman 20
DZ - Algeria 19
RO - Romania 18
AE - Emirati Arabi Uniti 17
IR - Iran 16
AZ - Azerbaigian 15
CH - Svizzera 15
RS - Serbia 13
AU - Australia 12
CR - Costa Rica 12
BO - Bolivia 11
SN - Senegal 11
TH - Thailandia 11
BY - Bielorussia 10
PA - Panama 10
PT - Portogallo 10
HN - Honduras 9
PS - Palestinian Territory 9
DO - Repubblica Dominicana 8
HU - Ungheria 8
LB - Libano 8
TT - Trinidad e Tobago 8
TW - Taiwan 7
AO - Angola 6
EU - Europa 6
GE - Georgia 6
GT - Guatemala 6
KG - Kirghizistan 6
NI - Nicaragua 6
BG - Bulgaria 5
BH - Bahrain 5
BS - Bahamas 5
EE - Estonia 5
GR - Grecia 5
HR - Croazia 5
KW - Kuwait 5
MD - Moldavia 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BN - Brunei Darussalam 4
KH - Cambogia 4
MT - Malta 4
NG - Nigeria 4
Totale 48.402
Città #
Fairfield 3.129
Ashburn 2.560
Singapore 2.049
Woodbridge 2.044
Chandler 1.572
Houston 1.569
Seattle 1.333
Hong Kong 1.177
San Jose 1.175
Cambridge 1.125
Wilmington 1.032
Ann Arbor 987
Jacksonville 986
Milan 909
Nyköping 851
Beijing 629
New York 535
Los Angeles 386
Lawrence 375
Roxbury 374
Lauterbourg 364
Rome 319
Nanjing 291
Dallas 268
Bari 266
Des Moines 254
Boardman 237
Ho Chi Minh City 208
Helsinki 207
Munich 171
Abidjan 169
São Paulo 167
Princeton 164
San Diego 155
Brooklyn 151
Santa Clara 141
Inglewood 134
Council Bluffs 126
Hanoi 120
Buffalo 114
Columbus 112
Moscow 99
Shenyang 92
Hebei 89
Falkenstein 87
London 87
Nanchang 87
Dearborn 80
Chicago 75
Figino 73
Brussels 71
Frankfurt am Main 70
Dublin 68
Jakarta 68
Jiaxing 68
Johannesburg 63
Tianjin 63
Rio de Janeiro 62
Warsaw 62
Changsha 61
Redwood City 61
Pune 60
Tashkent 57
Baghdad 55
Denver 55
Atlanta 53
Montreal 53
Turin 53
Tokyo 52
Chennai 51
Paris 51
Belo Horizonte 49
Turku 43
Nuremberg 42
The Dalles 42
Toronto 42
Guangzhou 40
Orem 39
Brasília 38
Marseille 38
Dong Ket 37
San Francisco 37
Shanghai 36
Curitiba 35
Naples 35
Mexico City 33
Dhaka 32
Phoenix 32
Lahore 29
Boston 28
Porto Alegre 28
Florence 27
Guayaquil 27
Quito 27
Stockholm 27
Haiphong 26
Jinan 26
Ankara 25
Jeddah 25
Medellín 25
Totale 31.931
Nome #
Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia 739
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 255
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 252
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome 235
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 225
Monosomal karyotype in myeloid neoplasias: a literature review 224
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 221
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11) 214
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 213
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 211
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients 210
Isolation and characterization of neural stem cells from dystrophic mdx mouse 204
Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA 202
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 202
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 201
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 200
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 199
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia 198
A fractal analysis of the spatial distribution of tumoral mast cells in lymph nodes and bone marrow 195
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 195
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 195
A novel chromosomal translocation t(3;7)(q26;q21)in myeloid leukemia resulting in overexpression of EVI1 192
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese" 191
Molecular cytogenetic study of instability at 1q21∼q32 in adult acute lymphoblastic leukemia 188
A role of light as potential biomarker for progression of smoldering to symptomatic multiple myeloma 188
Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9) 187
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 187
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1 184
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 183
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia 181
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients 180
Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation 180
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 180
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 178
A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene. 176
Cardiovascular events and intensity of treatment in polycythemia vera. 176
Non-treatment-related chronic myeloid leukemia as a second malignancy 175
Pericentric chromosome 8 inversion associated with the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases 170
Decreased TET2 gene expression during chronic myeloid leukemia progression 169
Vascular Endothelial Growth Factor Serum Levels Are Elevated in Patients with Hereditary Hemorrhagic Telangiectasia 169
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 169
Iron chelation therapy induces hematological response in transfusion dependent patient with myeloid malignancies 169
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma 168
The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia 168
t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene 167
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 167
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 166
Skin lesions in chronic myeloid leukemia patients during dasatinib treatment 164
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes 163
"Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia 162
CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: THE REAL LIFE EXPERIENCE OF RETE EMATOLOGICA PUGLIESE (REP) 162
Impact of bone marrow aspirate tregs on the response rate of younger newly diagnosed acute myeloid leukemia patients 162
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 160
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 160
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 160
A novel translocation t(14;15)(q32;q24) bearing deletion on der(14) in Philadelphia-positive chronic myeloid leukemia 159
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints 156
Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements 156
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 155
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 155
Differences among young adults, adults, and elderly chronic myeloid leukemia patients. 155
Next-Generation Sequencing in Acute Lymphoblastic Leukemia 155
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 154
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 154
ANALYSIS OF PROGNOSTIC FACTORS AND TIME TO FIRST TREATMENT IN YOUNG PATIENTS (<55 YEARS) WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE CENTER EXPERIENCE 152
Molecular cytogenetic findings supporting the evidence of a biclonal origin in acute myeloid leukemia 151
Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma 151
Concomitant primary polycythemia vera and follicle center cell non-Hodgkin lymphoma: a case report and review of the literature 151
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 151
A novel translocation t(2;9)(q14;p12) in AML-M2 with an uncommon phenotype: myeloperoxidase-positive and myeloid antigen-negative 150
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 150
Acute myeloblastic leukemia with minimal myeloid differentiation featuring a three-way translocation t(8;13;14) 149
Typhlitis complicating induction therapy in adult acute myeloid leukemia 149
CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds? 148
CT-guided needle biopsy performed with modified coaxial technique in the diagnosis of malignant lymphomas 147
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 146
Concomitant tetrasomy 3q and trisomy 18 in CD5(-), CD13(+) chronic lymphocytic leukemia 144
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 144
After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia 144
Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a PH-positive chronic myeloid leukemia 143
Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience. 143
DARA-VD VERSUS DARA-RD AS SALVAGE THERAPY FOR PATIENTS WITH MYELOMA. INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY RETE EMATOLOGICA PUGLIESE 142
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 141
A rare case of IgM-Multiple Myeloma 141
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 140
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 140
A case of light chain (AL) amyloidosis associated with IgD Multiple Myeloma (MM): clinical features, laboratory findings and outcome 139
Sclerostin is overexpressed by plasma cells from multiple myeloma patients 138
Submicroscopic deletions in an acute myelocytic leukemia case with a four-way t(8;11;16;21) 138
Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia 138
FLAG-Ida Regimen as Bridge Therapy to Allotransplantation in Refractory/Relapsed Acute Myeloid Leukemia Patients 138
Retinal abnormalities in newly diagnosed adult acute myeloid leukemia 138
Analysis of percent identity of IGHV mutation as prognostic factor in CLL patients treated with fludarabine, cyclofosfamide and rituximab: a single centre experience 138
Autoimmune Myelofibrosis: report of three cases and review of the literature 137
Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases 137
Concomitant tetrasomy 3q and trisomy 18 in CD5- CD13+ chronic lymphocytic leukemia 136
SETBP1 dysregulation in congenital disorders and myeloid neoplasms 136
SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia. 136
Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia 135
A novel translocation t(1;7) (p36;q34) in three patients with acute myeloid leukaemia 134
Totale 17.425
Categoria #
all - tutte 191.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 191.699


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.679 205 263 26 89 124 258 129 123 206 218 447 591
2022/20234.148 610 495 252 349 480 586 42 462 683 31 76 82
2023/20241.759 160 277 73 88 180 596 32 49 9 62 28 205
2024/20256.607 192 123 537 273 178 575 616 597 298 392 939 1.887
2025/202615.578 1.985 658 986 1.797 1.667 820 1.525 419 2.154 1.382 448 1.737
2026/2027380 380 0 0 0 0 0 0 0 0 0 0 0
Totale 49.405